Jim Simons’s CollPlant Biotechnologies CLGN Stock Holding History

Jim Simons’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.5K	Buy	6,150 +4,470	+266%	+$17.2K	﹤0.01%	3089
2026 Q1	$9K	Sell	1,680 -80	-5%	-$807	﹤0.01%	3201
2025 Q4	$24.6K	Sell	1,760 -430	-20%	-$8.8K	﹤0.01%	3134
2025 Q3	$58.9K	Sell	2,190 -1,970	-47%	-$47K	﹤0.01%	3320
2025 Q2	$56.6K	Buy	4,160 +3,130	+304%	+$64.8K	﹤0.01%	3378
2025 Q1	$26.6K	Sell	1,030 -30	-3%	-$1.06K	﹤0.01%	3346
2024 Q4	$38.2K	Buy	+1,060	New	+$43.1K	﹤0.01%	3421
2021 Q4	–	Sell	-1,000	Closed	-$169K	–	3934
2021 Q3	$169K	Buy	+1,000	New	+$180K	﹤0.01%	3235
2020 Q4	–	Sell	-1,280	Closed	-$107K	–	3411
2020 Q3	$107K	Buy	1,280 +10	+0.8%	+$900	﹤0.01%	3209
2020 Q2	$127K	Buy	+1,270	New	+$131K	﹤0.01%	3238

Other funds holding CLGN

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

LWMI

Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return

Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

FIA

FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jim Simons's CLGN Position: Q2 2026 in Review

Jim Simons increased its CollPlant Biotechnologies (CLGN) stake by 266% in Q2 2026, buying an estimated $17.2K and bringing the position to 6,150 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3089.

Jim Simons first reported a position in CLGN in Q2 2020 and has held it in 10 quarters since. The position peaked at $169K in Q3 2021. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

Jim Simons held 6,150 shares of CollPlant Biotechnologies worth $21.5K as of Q2 2026.
Jim Simons bought 4,470 CollPlant Biotechnologies shares in Q2 2026, an estimated $17.2K.
CollPlant Biotechnologies made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #3089 holding.
Jim Simons first reported a position in CollPlant Biotechnologies in Q2 2020 and has held it in 10 quarters since.
Jim Simons's CollPlant Biotechnologies position peaked at $169K in Q3 2021.
15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.